Platform Service
The SG Cap™ Total Service Based on the Multiplex Immuno-diagnosis Original Technology
The SG Cap™ Drug Target Identification(SG ID™)is the identifying service of novel target substances,
which is based on the SG Cap™ immobilized chip technology of PCL with LC-MS/MS.
The fused SG Cap™ immobilizes the most active status with undistorted, High-integration fixation of target substance.
It is possible to provide the new drug development total solution service
and identify the interaction among of intracellular protein, compound and biotherapeutic candidates.
which is based on the SG Cap™ immobilized chip technology of PCL with LC-MS/MS.
The fused SG Cap™ immobilizes the most active status with undistorted, High-integration fixation of target substance.
It is possible to provide the new drug development total solution service
and identify the interaction among of intracellular protein, compound and biotherapeutic candidates.
| Identification of Drug-protein mutual coupling and interaction partner exploration |
|---|
| 1 immobilized new drug candidate and collecting target material by inter affinity binding |
| 2 Target protein identification by MASS Spec |
| Figure out the medical action mechanism through Identifying the inter-partner of biotherapeutic candidates, suitable for High throughput technology |
|---|
| 1 It is possible to search the new drug candidate for undeveloped various disease through the chemical library approved from FDA |
| 2 Provide the high value rediscover opportunity of low risk compound |
| 3 For not available to interaction identification in current research method, it is suitable. |
